Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sufit

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
JAMA|November 16, 2017
Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical TrialMary M McDermott, Luigi Ferrucci, Lu Tian, et al.
Journal of the American Heart Association|July 27, 2022
Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical TrialMichael M Hammond, Bonnie Spring, W Jack Rejeski, et al.
Circulation Research|February 21, 2020
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical TrialMary M McDermott, Michael H Criqui, Kathryn Domanchuk, et al.
JAMA|April 6, 2021
Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical TrialMary M McDermott, Bonnie Spring, Lu Tian, et al.
Nature Communications|June 13, 2024
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trialMary M McDermott, Christopher R Martens, Kathryn J Domanchuk, et al.
Journal of the American Heart Association|August 29, 2023
Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE TrialMary O Whipple, Angela Fidler Pfammatter, Bonnie Spring, et al.
Journal of Vascular Surgery|January 8, 2025
Hepatocyte growth factor for walking performance in peripheral artery diseaseMary M McDermott, Robert Sufit, Kathryn J Domanchuk, et al.
JAMA|November 8, 2025
Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical TrialMary M McDermott, Kathryn J Domanchuk, Lu Tian, et al.
Annals of Neurology|September 11, 2009
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIPetra Kaufmann, John L P Thompson, Gilberto Levy, et al.
Neurobiology of Aging|September 11, 2012
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1Kreshnik B Ahmeti, Senda Ajroud-Driss, Ammar Al-Chalabi, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
JAMA|November 16, 2017
Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical TrialMary M McDermott, Luigi Ferrucci, Lu Tian, et al.
Journal of the American Heart Association|July 27, 2022
Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical TrialMichael M Hammond, Bonnie Spring, W Jack Rejeski, et al.
Circulation Research|February 21, 2020
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical TrialMary M McDermott, Michael H Criqui, Kathryn Domanchuk, et al.
JAMA|April 6, 2021
Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical TrialMary M McDermott, Bonnie Spring, Lu Tian, et al.
Nature Communications|June 13, 2024
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trialMary M McDermott, Christopher R Martens, Kathryn J Domanchuk, et al.
Journal of the American Heart Association|August 29, 2023
Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE TrialMary O Whipple, Angela Fidler Pfammatter, Bonnie Spring, et al.
Journal of Vascular Surgery|January 8, 2025
Hepatocyte growth factor for walking performance in peripheral artery diseaseMary M McDermott, Robert Sufit, Kathryn J Domanchuk, et al.
JAMA|November 8, 2025
Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical TrialMary M McDermott, Kathryn J Domanchuk, Lu Tian, et al.
Annals of Neurology|September 11, 2009
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIPetra Kaufmann, John L P Thompson, Gilberto Levy, et al.
Neurobiology of Aging|September 11, 2012
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1Kreshnik B Ahmeti, Senda Ajroud-Driss, Ammar Al-Chalabi, et al.
Pageof 4